Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2010
05/19/2010EP2186902A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
05/19/2010EP2186896A1 Cancer antigen peptides derived from WT1
05/19/2010EP2186823A1 Gene therapy for renal failure
05/19/2010EP2186821A1 Protein with promoting effects for axonal growth of neurons of central nervous system
05/19/2010EP2186820A1 Protein-protein interactions in human immunodeficiency virus
05/19/2010EP2186530A1 Promoters exhibiting endothelial cell specificity and methods of using same
05/19/2010EP2186528A1 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor
05/19/2010EP2186524A1 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP2185732A1 Cancer associated gene ly6k
05/19/2010EP2185696A1 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
05/19/2010EP2185578A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof
05/19/2010EP2185192A2 Lentiviral gene transfer vectors and their medicinal applications
05/19/2010EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy
05/19/2010EP1292671B9 Method for obtaining characterised muscle-derived cell populations and uses
05/19/2010EP1214097B9 Nucleic acids encoding polyepitope polypeptides
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010EP0888374B1 HIGH AFFINITY NUCLEIC ACID LIGANDS OF THE COMPLEMENT SYSTEM PROTEIN C1q
05/19/2010CN101711278A T4 bacteriophage bound to a substrate
05/19/2010CN101709292A Recombinant adenovirus, and preparation method and application thereof
05/19/2010CN101708167A Intraocular nano-particle frozen-dried powder and method for preparing same
05/19/2010CN101037688B Small molecule interfering RNA and its anti-tumor use
05/19/2010CN101011577B Polyamide dendroid polymer nano particle loading survivin small molecule RNA
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718628 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation
05/18/2010US7718627 Plasmid comprising nucleotide sequences coding immunoglobulin complementary determining regions specific to tumor antigen (5T4); for use in delivering product and/or nucleotide sequences of interest to tumor; drug delivery
05/18/2010US7718626 ErbB3 binding protein compositions and methods of use
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718428 using an exogenously-derived colony-stimulating factor 5 hyaluronidase (CSF5hyaluronidase) for treatment of myelosuppression as may occur after irradiation, chemotherapy or other diseases where an increase in leukocyte levels may be beneficial
05/18/2010US7718424 AAV4 vector and uses thereof
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718382 Method for identifying compounds for treatment of pain
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010US7718165 live Plasmodium organism that is genetically engineered to disrupt a liver-stage-specific gene function; used for inoculating a vertebrate host against malaria
05/18/2010US7718157 Targeted lipid particles
05/18/2010CA2557882C Defective packaging non-oncoviral vectors based on mpmv and hiv
05/18/2010CA2424619C Method for coating fine particles with lipid membrane
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/18/2010CA2216717C Compositions for the diagnosis, prevention, and treatment of tumor progression
05/14/2010WO2010054266A2 Multiblock copolymers
05/14/2010WO2010054167A2 Limited proteolysis of cd2ap and progression of renal disease
05/14/2010WO2010053978A2 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010WO2010053971A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides
05/14/2010WO2010053199A1 Pharmaceutical composition for treating prostate cancer, and method for treating prostate cancer
05/14/2010WO2010052828A1 Pharmaceutical agent for nonischemic myocardial disorders
05/14/2010WO2010052326A1 Small interfering rna delivery
05/14/2010WO2010051820A1 Multiplexed cytokine vaccination
05/14/2010WO2010051643A1 Transfection with magnetic nanoparticles and ultrasound
05/14/2010WO2010051639A1 Use of mir-126 for enhancing hematopoietic stem cell engraftment, for isolating hematopoietic stem cells, and for treating and monitoring the treatment of acute myeloid leukemia
05/14/2010WO2010033773A3 Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways
05/14/2010WO2010023544A4 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction
05/14/2010WO2010019847A3 Aptamer inhibition of thrombus formation
05/14/2010WO2010017264A3 Photo-crosslinked nucleic acid hydrogels
05/14/2010WO2010014218A3 Puf-a and related compounds for treatment of retinopathies and sight-threatening ophthalmologic disorders
05/14/2010WO2010009312A3 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use
05/14/2010CA2742880A1 Multiblock copolymers
05/14/2010CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010CA2742151A1 Transfection with magnetic nanoparticles and ultrasound
05/13/2010US20100121255 Compound
05/13/2010US20100120897 Novel helper plasmid, defective sindbis viral vectors and methods of use thereof
05/13/2010US20100120894 Intracellular DNA receptor
05/13/2010US20100120892 Methods and compositions for the inhibition of stat5 in prostate cancer cells
05/13/2010US20100120015 Method of collecting placental stem cells
05/13/2010US20100119546 Vaccine against african horse sickness virus
05/13/2010US20100119545 Modified vaccinia ankara virus variant
05/13/2010US20100119543 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
05/13/2010US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
05/13/2010US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
05/13/2010US20100119513 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
05/12/2010EP2184352A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer
05/12/2010EP2184296A1 Fibroblast growth factor (fgf23) and methods for use
05/12/2010EP2184054A1 Small Interfering RNA Delivery
05/12/2010EP2183362A2 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
05/12/2010EP1829972B1 DNA sequences having anti-repressor activity
05/12/2010EP1711187B1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
05/12/2010EP1706489B1 Oligomeric compounds for the modulation of bcl-2
05/12/2010EP1436397B1 Hepatitis c virus vaccine
05/12/2010CN1981887B Therapeutic use of growth factor, and delivery device, especially for the treatment of intima hyperplasia
05/12/2010CN1966683B Recombinant adenovirus for expression of novel tumour suppressor gene p53
05/12/2010CN1944655B Recombinant adenovirus of target-oriented coexpressed new p53 and P53AIP1
05/12/2010CN1944647B Dopamine receptor new sub-type D5B gene and coded protein and use
05/12/2010CN1927405B Combination immunizing preparation comprising recombinant plasmid and duplicate deficit type recombinant adenovirus
05/12/2010CN1896235B Micromolecular RNA medicine for inhibiting osteopontin expression and its expression system
05/12/2010CN1884530B Human XIAP target gene siRNA expression template
05/12/2010CN1843506B Medicine containing bacillus tubercle vaccine
05/12/2010CN1829523B Viral vectors
05/12/2010CN1798764B Peptide inhibitors of toxins derived from LL-37
05/12/2010CN1630663B Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
05/12/2010CN1350578B Recombinant influenza viruses for vaccines and gene therapy
05/12/2010CN101705241A Method for preparing recombined blue algae antiviral protein and application thereof
05/12/2010CN101705228A SiRNA for inhibiting human AP-2alpha gene expression and anti-breast cancer application thereof
05/12/2010CN101705227A SiRNA for inhibiting human AP-2alpha gene expression and anti-cervical cancer application thereof
05/12/2010CN101704892A Anti-uPAR humanized antibody, coding gene and application thereof
05/12/2010CN101703783A Method for preparing glucocorticoid grafted gene drug delivery vector
05/12/2010CN101703770A Polyvalent DNA vaccine in ovo
05/12/2010CN101703761A Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/12/2010CN101138636B Gene medicine conveying system and method of preparing the same
05/12/2010CN101130771B Nucleotide molecule SR3B2 and application of the same in producing antidiabetic medicament
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 870